212 related articles for article (PubMed ID: 36057322)
21. Combined Endometrial Ablation and Levonorgestrel Intrauterine System Use in Women With Dysmenorrhea and Heavy Menstrual Bleeding: Novel Approach for Challenging Cases.
Papadakis EP; El-Nashar SA; Laughlin-Tommaso SK; Shazly SA; Hopkins MR; Breitkopf DM; Famuyide AO
J Minim Invasive Gynecol; 2015; 22(7):1203-7. PubMed ID: 26122898
[TBL] [Abstract][Full Text] [Related]
22. The efficacy of the levonorgestrel-releasing intrauterine system in perimenopausal women with menorrhagia or dysmenorrhea.
Yoo HJ; Lee MA; Ko YB; Yang JB; Kang BH; Lee KH
Arch Gynecol Obstet; 2012 Jan; 285(1):161-6. PubMed ID: 21671063
[TBL] [Abstract][Full Text] [Related]
23. [A prospective study on the effects of levonorgestrel-releasing intrauterine system for adenomyosis with menorrhagia].
Li L; Leng JH; Shi JH; Zhang JJ; Jia SZ; Li XY; Dai Y; Zhang JR; Li T; Xu XX; Liu ZZ; You SS; Chang XY; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2016 Jun; 51(6):424-30. PubMed ID: 27356477
[TBL] [Abstract][Full Text] [Related]
24. Feasibility and Effectiveness of Hysteroscopic Suture Fixation of the Levonorgestrel-Releasing Intrauterine System in the Treatment of Adenomyosis.
Lv N; Guo J; Yuan Q; Shen S; Chen Q; Tong J
J Minim Invasive Gynecol; 2024 Jan; 31(1):57-63. PubMed ID: 37838016
[TBL] [Abstract][Full Text] [Related]
25. Bleeding pattern difference between levonorgestrel intrauterine system and copper intrauterine devices inserted immediately post-abortion: a multicenter, prospective, observational cohort study in Chinese women.
Chen X; Li Q; Wang X; Chen J; Lv W; Shi B; Wang H; Luo J; Li J
Curr Med Res Opin; 2018 May; 34(5):873-880. PubMed ID: 29298525
[TBL] [Abstract][Full Text] [Related]
26. Role of levonorgestrel-releasing intrauterine system in dysmenorrhea due to adenomyosis and the influence on ovarian function.
Ji F; Yang XH; Ai Xing Zi AL; Ha Ni Ke Zi TX; He Y; Ding Y
Clin Exp Obstet Gynecol; 2014; 41(6):677-80. PubMed ID: 25566593
[TBL] [Abstract][Full Text] [Related]
27. Emerging indications for the levonorgestrel-releasing intrauterine system (LNG-IUS).
Heikinheimo O; Gemzell-Danielsson K
Acta Obstet Gynecol Scand; 2012 Jan; 91(1):3-9. PubMed ID: 22007693
[TBL] [Abstract][Full Text] [Related]
28. [Efficacy and safety of low-dose levonorgestrel-releasing intrauterine system in Chinese women: a multicenter, single-arm, open labeled interventional trial].
Qian CF; Fan GS; Liao QP; Wu SY; La DD; Di W; Dong BH; Liu HW; Tang LD; Xiong ZA; Zhang HW; Hu YL; Yang NM; Ren ML; Shi H; Deng GP; Huang ZR
Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):409-413. PubMed ID: 29961284
[No Abstract] [Full Text] [Related]
29. Comparison of combined transcervical resection of the endometrium and levonorgestrel-containing intrauterine system treatment versus levonorgestrel-containing intrauterine system treatment alone in women with adenomyosis: a prospective clinical trial.
Zheng J; Xia E; Li TC; Sun X
J Reprod Med; 2013; 58(7-8):285-90. PubMed ID: 23947077
[TBL] [Abstract][Full Text] [Related]
30. The effect on menstrual blood loss in women with uterine fibroids of a novel "frameless" intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E
Eur J Obstet Gynecol Reprod Biol; 2002 Apr; 102(1):74-9. PubMed ID: 12039094
[TBL] [Abstract][Full Text] [Related]
31. Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial.
Shaaban OM; Ali MK; Sabra AM; Abd El Aal DE
Contraception; 2015 Oct; 92(4):301-7. PubMed ID: 26071673
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of combined levonorgestrel-releasing intrauterine system with gonadotropin-releasing hormone analog for the treatment of adenomyosis.
Zhang P; Song K; Li L; Yukuwa K; Kong B
Med Princ Pract; 2013; 22(5):480-3. PubMed ID: 23796720
[TBL] [Abstract][Full Text] [Related]
33. Predictive factors for failure of the levonorgestrel releasing intrauterine system in women with heavy menstrual bleeding.
Beelen P; van den Brink MJ; Herman MC; Geomini PM; Duijnhoven RG; Bongers MY
BMC Womens Health; 2021 Feb; 21(1):57. PubMed ID: 33563257
[TBL] [Abstract][Full Text] [Related]
34. [Effects of levonorgestrel-releasing intrauterine system on pain and recurrence associated with endometriosis and adenomyosis].
Deng S; Lang JH; Leng JH; Liu ZF; Sun DW; Zhu L
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):664-8. PubMed ID: 17199919
[TBL] [Abstract][Full Text] [Related]
35. The role of levonorgestrel-releasing intrauterine system for recurrence prevention after conservative surgery among patients with coexistent ovarian endometrioma and diffuse adenomyosis: A retrospective case control study with long-term follow up.
Shi JH; Zhu SY; Li XY; Dai Y; Leng JH
J Gynecol Obstet Hum Reprod; 2023 May; 52(5):102572. PubMed ID: 36914113
[TBL] [Abstract][Full Text] [Related]
36. Utility of the Levonorgestrel-Releasing Intrauterine System in the Treatment of Abnormal Uterine Bleeding and Dysmenorrhea: A Narrative Review.
Bianchi P; Guo SW; Habiba M; Benagiano G
J Clin Med; 2022 Oct; 11(19):. PubMed ID: 36233703
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of action of the levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding.
Cihangir U; Ebru A; Murat E; Levent Y
Int J Gynaecol Obstet; 2013 Nov; 123(2):146-9. PubMed ID: 24028852
[TBL] [Abstract][Full Text] [Related]
38. Laparoscopic adenomyomectomy combined with levonorgestrel-releasing intrauterine system in the treatment of adenomyosis: Feasibility and effectiveness.
Sun F; Zhang Y; You M; Yang Y; Yu Y; Xu H
J Obstet Gynaecol Res; 2021 Feb; 47(2):613-620. PubMed ID: 33174318
[TBL] [Abstract][Full Text] [Related]
39. Factors affecting the spontaneous expulsion of the levonorgestrel-releasing intrauterine system.
Youm J; Lee HJ; Kim SK; Kim H; Jee BC
Int J Gynaecol Obstet; 2014 Aug; 126(2):165-9. PubMed ID: 24825498
[TBL] [Abstract][Full Text] [Related]
40. Endometrial ablation plus levonorgestrel releasing intrauterine system versus endometrial ablation alone in women with heavy menstrual bleeding: study protocol of a multicentre randomised controlled trial; MIRA2 trial.
Oderkerk TJ; Beelen P; Geomini PMAJ; Herman MC; Leemans JC; Duijnhoven RG; Bosmans JE; Pannekoek JN; Clark TJ; Mol BWJ; Bongers MY
BMC Womens Health; 2022 Jun; 22(1):257. PubMed ID: 35761328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
